Clinical Trials Directory

Trials / Completed

CompletedNCT01681316

Danhong Injection in the Treatment of Chronic Stable Angina

A Randomized, Multi-center, Double-blind, Placebo-controlled Trial of Danhong Injection in the Treatment of Chronic Stable Angina

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
920 (actual)
Sponsor
China Academy of Chinese Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effect of Danhong Injection on the relief of angina with the use of the Seattle Angina Questionnaire among patients with stable angina patients

Conditions

Interventions

TypeNameDescription
DRUGDanhong injectionA kind of injection made from two kind of Chinese herbs: salvia miltiorrhiza and safflower
OTHERStandard medical careStandard medical care is in accordance with China Guideline for the diagnosis and treatment of Chronic Stable Angina (2007).
DRUGPlacebo0.9% saline added into 250ml 0.9% saline by an independent research nurse, sealed with brown bag in order to make the investigators and patients blinded, using brown infusion tube for infusion.

Timeline

Start date
2012-12-01
Primary completion
2016-10-01
Completion
2016-10-01
First posted
2012-09-07
Last updated
2016-10-12

Locations

31 sites across 1 country: China

Source: ClinicalTrials.gov record NCT01681316. Inclusion in this directory is not an endorsement.